какво е leflunomide ratiopharm за?
leflunomide is indicated for the treatment of adult patients with active rheumatoid arthritis as a disease modifying antirheumatic drug dmard active psoriatic arthritis recent or concurrent treatment with hepatotoxic or haematotoxic dmards e g methotrexate may result in an increased risk of serious adverse reactions therefore the initiation of leflunomide treatment has to be carefully considered regarding these benefit risk aspects moreover switching from leflunomide to another dmard without following the washout procedure may also increase the risk of serious adverse reactions even for a long time after the switching